About Our Translational Projects

The Center for Molecular and Translational Medicine (MolMed) provides a forum to accelerate and enhance collaboration among faculty whose research is devoted to the translation of basic sciences into potential therapeutics, medical devices or diagnostics. With this initiative, UC Riverside and the School of Medicine commit to devote resources to assist on the development of novel treatments.

Summaries of our current research projects may be found by clicking the links below.

Immunology, Infectious, Cardiometabolic, and Degenerative Diseases

• PTPN2 and Associated Genes for Pharmaceutical Intervention Against Inflammatory Bowel Disease, Celiac Disease, and Type 1 Diabetes
• Small Molecular Modulators for GLP1 Receptor for the Treatment of Diabetes
• The Immunology of Infectious Diseases
• Immune Surveillance in Mucosal Tissues
• Targeting SUMOylation for Influenza Virus Infection and Cancers
• Complement System-Mediated Inflammatory and Autoimmune Diseases
• Toxoplasma Infections and Neurodegenerative Diseases
• Novel Antimalarial Agents Directed by Systems Biology Approaches and Natural Products
• Macular Degeneration
• Identification of small molecule inhibitors against Zika virus infection
• Cardiovascular and metabolic diseases linked to the PXR receptor and IKKβ

Oncology

• Targeted Delivery of Drugs to Cancer Cells: Changing the Face of Chemotherapy
• Targeting Apoptosis via Chemical Design
• Targeting a Specific Metastasis-Promoting Form of the Prolactin Receptor in Breast, Ovarian and Prostate Cancer
• The SUMO and Ubiquitin Pathway as Targets for Anti-Cancer Therapeutics
• Novel Strategies to Combat Glioblastoma Multiforme (GBM)
• Highly Selective Monoclonal Antibody Treatments for Metastatic Spread of Breast Cancer
• Selective Proteasome Inhibitors Against Multiple Myeloma and Solid Tumors

Neurodegenerative Diseases, Stroke & Traumatic Brain Injury

• Targeting the EphA4 receptor for the treatment of Amyotrophic Lateral Sclerosis (ALS)
• Fragile X Syndrome (FXS) and Alzheimer’s Disease
• Stroke and Brain Injury
• Targeting Remyelination and Neuroprotection in Multiple Sclerosis (MS)
• RNA Binding Proteins and RNA Processing as Targets for Brain Disorders